Hyperparathyroidism, Secondary Clinical Trial
Official title:
Randomized Clinical Trial of Subtotal Parathyroidectomy or Total Parathyroidectomy With Immediate Heterotopic Autograft in Chronic Renal Disease Patients Stage V Under Dialysis
This study evaluates the metabolic and clinical results of two well recognized and accepted surgical techniques in the management of severe hyperparathyroidism in patients under regular dialysis treatment.
Prospective randomized trial in the surgical management of severe hyperparathyroidism of chronic kidney disease stage V under dialysis. Patients will be randomized and they will be submitted to subtotal parathyroidectomy or total parathyroidectomy with immediate heterotopic autograft of 45 or 90 fragments of parathyroid tissue. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01134562 -
Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism
|
Phase 1 | |
Completed |
NCT02523209 -
Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal Transplantation
|
N/A | |
Completed |
NCT01922843 -
A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis
|
Phase 2 | |
Completed |
NCT01651000 -
Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
|
Phase 3 | |
Completed |
NCT00528788 -
How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis
|
Phase 4 | |
Completed |
NCT01181531 -
Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis
|
Phase 4 | |
Completed |
NCT05382988 -
Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After Parathyroidectomy
|
Phase 3 | |
Completed |
NCT02056730 -
The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid
|
Phase 4 | |
Completed |
NCT01704079 -
Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
|
Phase 3 | |
Completed |
NCT00397475 -
Evaluation of Colecalciferol Substitution in Dialysis Patients
|
N/A | |
Withdrawn |
NCT03063190 -
Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT02102204 -
Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis
|
Phase 3 | |
Recruiting |
NCT02273570 -
Optimal Anemia Treatment in End Stage Renal Disease (ERSD)
|
N/A | |
Completed |
NCT01788046 -
Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis
|
Phase 3 | |
Completed |
NCT01785849 -
Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis
|
Phase 3 | |
Terminated |
NCT01277510 -
Pediatric Chronic Kidney Disease Safety and Efficacy
|
Phase 3 | |
Terminated |
NCT01439867 -
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
|
Phase 2 | |
Completed |
NCT01134549 -
Safety, Tolerability and Pharmacokinetics of KAI-4169 in Healthy Male Volunteers
|
Phase 1 | |
Completed |
NCT01785875 -
Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis
|
Phase 3 | |
Completed |
NCT01290029 -
Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease
|
Phase 1 |